New drug STLX-2012 tested in healthy people for first time
Knowledge-focused
Not yet recruiting
This early-stage trial will test the safety and tolerability of a single dose of STLX-2012 in 32 healthy adults aged 18-55. Participants will receive either the drug or a placebo, and researchers will monitor side effects and how the drug moves through the body. The study is not …
Phase: PHASE1 • Sponsor: Stelexis BioSciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC